CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 100.0%

Compliant submissions 2

Incompliant submissions 0

Total trials 2

My Organizations' Clinical Trials

Showing 1175 of 2003 entries

View as:

Atherosclerosis in Rheumatoid Arthritis

Phase: N/A Priority: Normal

NCT ID: NCT00990730 Org: User:

Start: 09/30/09 End: 06/30/11 Due: 06/30/12

Optimizing Mindfulness Based Cognitive Therapy (MBCT) Maintenance

Phase: N/A Priority: Normal

NCT ID: NCT05859386 Org: User:

Start: 04/03/23 End: 02/19/24 Due: 02/19/25

Harnessing Health IT for Self-Management Support and Medication Activation in a Medicaid Health Plan

Phase: N/A Priority: Normal

NCT ID: NCT00683020 Org: User:

Start: 04/30/09 End: 04/30/12 Due: 04/30/13

UCSF Research Participant Registry

Phase: N/A Priority: Normal

NCT ID: NCT01717378 Org: User:

Start: 03/31/12 End: 02/28/15 Due: 02/28/16

Busulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer

Phase: N/A Priority: Normal

NCT ID: NCT00301912 Org: User:

Start: 01/31/02 End: - Due: -

Doctor-Patient Communication in Spanish

Phase: N/A Priority: Normal

NCT ID: NCT00187785 Org: User:

Start: 09/30/05 End: 12/31/06 Due: 12/31/07

Effect of Daily Calorie or Alternate-day Calorie Reductions on Risk for Cardiovascular Disease and Cancer

Phase: N/A Priority: Normal

NCT ID: NCT00467220 Org: User:

Start: 04/30/07 End: 12/17/15 Due: 12/17/16

Living Alone in Old Age With Cognitive Impairment

Phase: N/A Priority: Normal

NCT ID: NCT03330587 Org: User:

Start: 03/01/16 End: 05/31/25 Due: 05/31/26

Impact of Breast Cancer Treatment on Joint Health, Cartilage Composition, and Bone Structure in the Knee and Hand

Phase: N/A Priority: Normal

NCT ID: NCT04876378 Org: User:

Start: 05/18/20 End: 05/24/22 Due: 05/24/23

Providing "Good Sleep" for ICU Sedation

Phase: N/A Priority: Normal

NCT ID: NCT01342328 Org: User:

Start: 05/31/12 End: 11/01/18 Due: 11/01/19

Alpha Lipoic Acid and Insulin Resistance

Phase: N/A Priority: Normal

NCT ID: NCT00845156 Org: User:

Start: 01/31/08 End: 09/30/10 Due: 09/30/11

Inhaled NO in Prevention of Chronic Lung Disease

Phase: N/A Priority: Normal

NCT ID: NCT00000548 Org: User:

Start: 03/31/00 End: 02/28/06 Due: 02/28/07

Wire Instrumentation Using Radiofrequency Energy to Impact Transseptal Efficiency

Phase: N/A Priority: Normal

NCT ID: NCT04645342 Org: User:

Start: 11/30/20 End: 02/02/22 Due: 02/02/23

HIV Screening Take-up: Evaluating Incentives and Opt-out Strategies

Phase: N/A Priority: Normal

NCT ID: NCT01377857 Org: User:

Start: 05/31/11 End: 12/31/13 Due: 12/31/14

Defibrotide Prophylaxis of Transplant Associated-Thrombotic Microangiopathy for Neuroblastoma

Phase: N/A Priority: Normal

NCT ID: NCT06182410 Org: User:

Start: 08/01/24 End: 05/31/27 Due: 05/31/28

Maternal, Adiposity, Metabolism, and Stress Study

Phase: N/A Priority: Normal

NCT ID: NCT01307683 Org: User:

Start: 08/31/11 End: 12/31/15 Due: 12/31/16

Azithromycin for Child Survival in Niger: Delivery Trial

Phase: N/A Priority: Normal

NCT ID: NCT04774991 Org: User:

Start: 06/28/21 End: 06/30/23 Due: 06/30/24

Lemborexant in Delayed Sleep Phase Syndrome

Phase: N/A Priority: Normal

NCT ID: NCT06874855 Org: User:

Start: 03/13/23 End: 05/31/27 Due: 05/31/28

Excipient Effect on Drug Absorption in Humans

Phase: N/A Priority: Normal

NCT ID: NCT04534153 Org: User:

Start: 01/31/23 End: 08/31/25 Due: 08/31/26

Phase 2 Efficacy Study of Primaquine and Methylene Blue

Phase: N/A Priority: Normal

NCT ID: NCT02831023 Org: User:

Start: 07/31/16 End: 01/31/17 Due: 01/31/18

Preparing for Pharmacy-based Delivery of Long-acting Injectable Antiretroviral Therapy (LAI-ART)

Phase: N/A Priority: Normal

NCT ID: NCT05152953 Org: User:

Start: 06/08/22 End: 11/15/23 Due: 11/15/24

A Single Arm Study of Neurocognitive Outcomes in Patients With Brain Metastases Managed With Stereotactic Radiosurgery (SRS)

Phase: N/A Priority: Normal

NCT ID: NCT01821443 Org: User:

Start: 12/31/12 End: 10/22/15 Due: 10/22/16

Precision Care for Major Depressive Disorder

Phase: N/A Priority: Normal

NCT ID: NCT06580041 Org: User:

Start: 11/12/24 End: 09/01/29 Due: 09/01/30

Ceritinib + Trametinib in Patients With Advanced ALK-Positive Non-Small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal

NCT ID: NCT03087448 Org: User:

Start: 09/09/17 End: 04/30/22 Due: 04/30/23

Opioid and Cannabinoid Pharmacokinetic Interactions

Phase: N/A Priority: Normal

NCT ID: NCT00308555 Org: User:

Start: 05/31/06 End: 03/31/09 Due: 03/31/10

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Atherosclerosis in Rheumatoid Arthritis	NCT00990730	University of California, San Francisco	user2@example.com	None	2009-09-30	2011-06-30	2012-06-30	-	-	2025-07-14
Optimizing Mindfulness Based Cognitive Therapy (MBCT) Maintenance	NCT05859386	University of California, San Francisco	user2@example.com	None	2023-04-03	2024-02-19	2025-02-19	-	-	2025-07-14
Harnessing Health IT for Self-Management Support and Medication Activation in a Medicaid Health Plan	NCT00683020	University of California, San Francisco	user2@example.com	None	2009-04-30	2012-04-30	2013-04-30	-	-	2025-07-14
UCSF Research Participant Registry	NCT01717378	University of California, San Francisco	user2@example.com	None	2012-03-31	2015-02-28	2016-02-28	-	-	2025-07-14
Busulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer	NCT00301912	University of California, San Francisco	user2@example.com	None	2002-01-31	-	-	-	-	2025-07-14
Doctor-Patient Communication in Spanish	NCT00187785	University of California, San Francisco	user2@example.com	None	2005-09-30	2006-12-31	2007-12-31	-	-	2025-07-14
Effect of Daily Calorie or Alternate-day Calorie Reductions on Risk for Cardiovascular Disease and Cancer	NCT00467220	University of California, San Francisco	user2@example.com	None	2007-04-30	2015-12-17	2016-12-17	-	-	2025-07-14
Living Alone in Old Age With Cognitive Impairment	NCT03330587	University of California, San Francisco	user2@example.com	None	2016-03-01	2025-05-31	2026-05-31	-	-	2025-07-14
Impact of Breast Cancer Treatment on Joint Health, Cartilage Composition, and Bone Structure in the Knee and Hand	NCT04876378	University of California, San Francisco	user2@example.com	None	2020-05-18	2022-05-24	2023-05-24	-	-	2025-07-14
Providing "Good Sleep" for ICU Sedation	NCT01342328	University of California, San Francisco	user2@example.com	None	2012-05-31	2018-11-01	2019-11-01	-	-	2025-07-14
Alpha Lipoic Acid and Insulin Resistance	NCT00845156	University of California, San Francisco	user2@example.com	None	2008-01-31	2010-09-30	2011-09-30	-	-	2025-07-14
Inhaled NO in Prevention of Chronic Lung Disease	NCT00000548	University of California, San Francisco	user9@example.com	Compliant	2000-03-31	2006-02-28	2007-02-28	2025-07-01	-	2025-07-14
Wire Instrumentation Using Radiofrequency Energy to Impact Transseptal Efficiency	NCT04645342	University of California, San Francisco	user2@example.com	None	2020-11-30	2022-02-02	2023-02-02	-	-	2025-07-14
HIV Screening Take-up: Evaluating Incentives and Opt-out Strategies	NCT01377857	University of California, San Francisco	user2@example.com	None	2011-05-31	2013-12-31	2014-12-31	-	-	2025-07-14
Defibrotide Prophylaxis of Transplant Associated-Thrombotic Microangiopathy for Neuroblastoma	NCT06182410	University of California, San Francisco	user2@example.com	None	2024-08-01	2027-05-31	2028-05-31	-	-	2025-07-14
Maternal, Adiposity, Metabolism, and Stress Study	NCT01307683	University of California, San Francisco	user2@example.com	None	2011-08-31	2015-12-31	2016-12-31	-	-	2025-07-14
Azithromycin for Child Survival in Niger: Delivery Trial	NCT04774991	University of California, San Francisco	user2@example.com	None	2021-06-28	2023-06-30	2024-06-30	-	-	2025-07-14
Lemborexant in Delayed Sleep Phase Syndrome	NCT06874855	University of California, San Francisco	user2@example.com	None	2023-03-13	2027-05-31	2028-05-31	-	-	2025-07-14
Excipient Effect on Drug Absorption in Humans	NCT04534153	University of California, San Francisco	user2@example.com	None	2023-01-31	2025-08-31	2026-08-31	-	-	2025-07-14
Phase 2 Efficacy Study of Primaquine and Methylene Blue	NCT02831023	University of California, San Francisco	user2@example.com	None	2016-07-31	2017-01-31	2018-01-31	-	-	2025-07-14
Preparing for Pharmacy-based Delivery of Long-acting Injectable Antiretroviral Therapy (LAI-ART)	NCT05152953	University of California, San Francisco	user2@example.com	None	2022-06-08	2023-11-15	2024-11-15	-	-	2025-07-14
A Single Arm Study of Neurocognitive Outcomes in Patients With Brain Metastases Managed With Stereotactic Radiosurgery (SRS)	NCT01821443	University of California, San Francisco	user2@example.com	None	2012-12-31	2015-10-22	2016-10-22	-	-	2025-07-14
Precision Care for Major Depressive Disorder	NCT06580041	University of California, San Francisco	user2@example.com	None	2024-11-12	2029-09-01	2030-09-01	-	-	2025-07-14
Ceritinib + Trametinib in Patients With Advanced ALK-Positive Non-Small Cell Lung Cancer (NSCLC)	NCT03087448	University of California, San Francisco	user2@example.com	None	2017-09-09	2022-04-30	2023-04-30	-	-	2025-07-14
Opioid and Cannabinoid Pharmacokinetic Interactions	NCT00308555	University of California, San Francisco	user2@example.com	None	2006-05-31	2009-03-31	2010-03-31	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance